华兰股份：全资子公司拟出资1000万元设立合资公司

Group 1 - The core point of the article is that Hualan Co., Ltd. announced the establishment of a joint venture with Insilicom LLC's former CTO and a team led by Academician Liu Jun, focusing on drug repurposing and pharmacovigilance services using knowledge graphs and artificial intelligence technology [1] - Hualan's wholly-owned subsidiary, Hainan Lingqing Intelligent Pharmaceutical Technology Co., Ltd., will invest 6 million yuan and hold a 60% stake in the joint venture [1] - The joint venture aims to explore applications of artificial intelligence in pharmaceutical research and drug safety management [1]